Response to "Chronic cerebrospinal venous insufficiency,chlamydia and multiple sclerosis": CCSVI,Chlamydia pneumoniae and multiple sclerosis clarification

Lewis A. Chronic cerebrospinal venous insufficiency, chlamydia and multiple sclerosis. Phlebology 2018, 33: 695.

Thibault P Attia J Oldmeadow C. A prolonged antibiotic protocol to treat persistent Chlamydophila pneumoniae infection improves the extracranial venous circulation in multiple sclerosis. Phlebology 2018; 33: 397–406.

Rindfleisch E. Histologisches detail zu der grauen degeneration und Ruckenmarks. Arch Path Anat Physiol Klin Med 1863; 26: 474.

Charcot J-M. Sclerose des cordons lateraux de la moelle epiniere, chez une femme hysterique, atteinte de contracture permanente des quatre members. Union Medicale 1865; 25: 451–467.

Dawson JW. The histology of disseminated sclerosis. Trans Roy Soc Edinb 1916; 50: 517.

Steiner G. Krankheitserreger und gewebsbefund bei multipler sklerose. Vergleichend histologisch-parasitologische untersuchugen beo multipler sklerose und anderen spirochatosen. Berlin: Springer, 1931, pp. 108–120.

Steiner G. Multiple slerose. Ihre atiologie, pathologie, pathogenese und therapie. Berlin: Springer, 1962.

Putnam TJ Adler A. Vascular architecture of the lesions of multiple sclerosis. Arch Neurol Psychiat 1937; 38: 1–15.

Fog T. On the vessel-plaque relationship in the brain in multiple sclerosis. Acta Neurol Scand 1964; 40: 9–15.

Adams CW Poston RN Buk SJ et al . Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 1985; 69: 269–283.

Zamboni P. The big idea: iron dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 2006; 99: 589–593.

Zamboni P Galeotti R. The chronic cerebrospinal venous insufficiency syndrome. Phlebology 2010; 25: 269–279.

Zamboni P Galeotti R Menegatti E et al . A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009; 50: 1348–1358.

Zamboni P Tesio L Galimberti S et al . Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial JAMA Neurol 2018; 75: 35–43.

Thibault PK. Multiple sclerosis: a chronic infective cerebrospinal venulitis? Phlebology 2012; 27: 207–218.

Kurtzke JF. Multiple sclerosis in time and space – geographical clues to cause. J NeuroVirol 2000; 6: 134–140.

Zamboni P Tisato V Menegatti E. Ultrastructure of internal jugular vein defective valves. Phlebology 2015; 30: 644–647.

Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993; 6: 382–427.

Taylor-Robinson D Thomas BJ. Chlamydia pneumoniae in atherosclerotic tissue. J Infect Dis 2000; 181: 437–440.

Taylor-Robinson D Thomas BJ Goldin R et al . Chlamydia pneumoniae in infrequently examined blood vessels. J Clin Pathol 2002; 55: 218–220.

McKay KA Kwan V Duggan T et al . Risk factors associated with the onset of relapsing remitting and primary progressive multiple sclerosis: a systematic review. Biomed Res Int 2015; 2015: 817238.

Munger KL Peeling RW Hernán MA et al . Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology 2003; 14: 141–147.

Munger KL DeLorenze GN Levin LI et al . A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts. Neurology 2004; 62: 1799–1803.

Krametter D Niederwieser G Berghold A et al. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 2001; 7: 13–18.

Libbey JE Cusick MF Fujinami RS. Role of pathogens in multiple sclerosis. Int Rev Immunol 2014; 33: 266–283.

Lindsey J Patel S. PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid. Mult Scler 2008; 14: 147–152.

Mahony JB Chong S Coombes BK et al . Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells. J Clin Microbiol 2000; 38: 2622–2627.

Fukano H. Comparison of five PCR assays for detecting Chlamydia pneumoniae DNA. Microbiol Immunol 2004; 48: 441–448.

Ivanova MV Kolkova NI Morgunova EY et al . Role of chlamydia in multiple sclerosis. Bull Exp Biol Med 2015; 159: 646–648.

Woessner R Grauer MT Frese A et al . Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis. Infection 2006; 34: 342–344.

Gieffers J Rupp J Gebert A. First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydophila pneumoniae. Antimicrob Agents Chemother 2004; 48: 1402–1405.

Stratton CW Wheldon DB. Antimicrobial treatment of multiple sclerosis. Infection 2007; 35: 383–385.

Mitchell WM Stratton CW. Diagnosis and management of infection caused by chlamydia. United States Patent, US 6884784, 2005.

Metz LM Li D Traboulsee A et al . Glatiramer acetate in combination with minocycline in patients with relapsing–remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial. Mult Scler 2009; 15: 1183–1194.